Imported Layers Created using Figma Group Created using Figma Shape Created using Figma Shape Created using Figma Imported Layers Created using Figma Shape Created using Figma Shape Created using Figma Imported Layers Created using Figma Path Created using Figma logo Created using Figma “ Created using Figma Group Created using Figma
×

Harbour Outlook: Coronavirus contagion uncertainty

Harbour sails 2
Harbour team | Posted on Feb 11, 2020

Key points

  • The conflict between the US and Iran caused some market volatility but proved to be short lived.
  • Activity indicators were generally stronger in January. US manufacturing, which had been an area of weakness, posted a strong print in early February, well above expectations.
  • The US earnings season was very strong. At the time of writing, 320 S&P 500 companies have reported with 238 (74%) of those companies beating consensus earnings expectations.
  • The outbreak of Novel Coronavirus (2019-nCov), a relatively less deadly but more contagious coronavirus than SARS, will have an impact on global economic activity due to cities being in lockdown and supply chains being disrupted.
  • Interest rates and commodity prices have dropped substantially in response to the coronavirus outbreak. Equities, however, appear to have been supported by strong earnings and greater emphasis on the prior uptick in economic activity.

Key developments

Markets began 2020 on a bullish note as fears of an escalation in trade tensions between the US and China, and of a disorderly Brexit, were assuaged late in 2019. However, investor worry switched from trade wars to real wars with the US assassination of Iranian General, Qassem Soleimani, causing a military response from Iran. Fortunately, this conflict, which caused some short-term volatility, met a swift impasse.

Further volatility ensued later in January following the outbreak of Novel Coronavirus (2019-nCov). This triggered substantial shifts in asset classes. Those sharpest hit were Chinese A-shares, which resumed trading after an extended Chinese New Year break, which fell -7.9% on the first day of trading post the outbreak. China-related, commodity and tourism exposed stocks were also hit hard. Some healthcare stocks benefitted from expected higher healthcare spending. Stocks have recovered strongly in early February.   

Outside these two events, January gave investors plenty to be optimistic about. The US earnings season was especially strong once again allaying fears of an earnings recession. Technology companies fared especially well, with a staggering 36 out of the 38 companies who have reported so far beating consensus earnings estimates. Consumer goods companies also fared well with 82.5% of companies beating consensus estimates, further reinforcing the strength of the US consumer.

Global data surprises have been mostly positive recently, and geographically broad based. January survey data suggests the US manufacturing sector, which had been disappointing, responded positively to the “phase one” US – China trade deal that was agreed in December. Chinese data had been on the improve following stimulus measures introduced in Q4. Further Chinese stimulus has been announced to combat some of the anticipated economic impact from the coronavirus outbreak.

In New Zealand, the outlook continued to improve in January, aside from the coronavirus risk. The Government has substantially increased its spending plans over the past two months, turning out to be a better friend to the Reserve Bank of New Zealand (RBNZ) in supporting economic activity than most had anticipated. Not only has there been $12bn of infrastructure spending announced, Kāinga Ora announced on January 19th an additional $4bn of borrowing to help its ongoing state housing upgrades. This adds to a positive picture for the housing market where prices and activity have already been rising in response to lower mortgage rates.

What to watch

Coronavirus: At the time of writing, the number of new daily coronavirus cases are rising at a slower rate.  In previous virus outbreaks when new cases peak, it has been somewhat of a turning point in market confidence.

image001 v2image002
Source: Bloomberg

NZ Earnings Season: February will be the litmus test for local markets with the reporting season starting in earnest. We have already seen some “confessions” ahead of reporting season which largely seem to be idiosyncratic, stock-specific issues. We would expect some companies to call out the bushfires in Australia, plus the coronavirus as potentially impacting future earnings.

Market outlook and positioning

Within Harbour’s equity growth portfolios, the portfolios are overweight versus their benchmarks in selected quality growth companies in the information technology, consumer staples, healthcare and financials sectors, where the potential rate and sustainability of growth may not be fully reflected in share prices.  Conversely, the portfolio is underweight in the New Zealand consumer discretionary and energy sectors where disruption risk remains high, and the utilities, infrastructure, real estate and telecommunications sectors, where valuations are high relative to their potential growth. 

Within fixed interest portfolios, we started the month positioned for a shift in monetary policy towards neutral, but coronavirus forced us to consider downside risks. We had initially estimated that the market was not fully appreciating the extent to which data had improved over Q4. We expected that the RBNZ would acknowledge the better data but make it clear that no rate hike was on the horizon due to the persistent gap between current inflation and the top of the target band. This should remain a feature of the Monetary Policy Statement, when released on 12th February. However, with the coronavirus risks still highly uncertain, and with the possibility of the virus spreading outside China, we need to consider the likelihood of a flight to quality in financial markets and the possibility that growth would slow enough to trigger rate cuts by the RBNZ. Accordingly, we have added duration in our core funds, concentrating this in the 0 - 3-year sector, where rate cuts would be most influential. Long term bond yields remain expensive and could reverse sharply if we are fortunate enough to see a fairly rapid decline in new cases of the virus, as this would enable economic damage to be short-lived.

In multi-asset portfolios, we are cautiously positioned. This reflects two key factors. Firstly, the risks posed by the coronavirus outbreak gives rise to some near-term uncertainty. Secondly, the equity market has had several tailwinds in recent months, which has expanded valuation multiples. Taking a more medium-term view, we remain optimistic that equity markets should edge higher. Economic data have been improving (notwithstanding the risk posed by coronavirus), equity issuance is low, buybacks are high and earnings look increasingly resilient.

IMPORTANT NOTICE AND DISCLAIMER
Harbour Asset Management Limited is the issuer and manager of the Harbour Investment Funds. Investors must receive and should read carefully the Product Disclosure Statement, available at www.harbourasset.co.nz. We are required to publish quarterly Fund updates showing returns and total fees during the previous year, also available at www.harbourasset.co.nz. Harbour Asset Management Limited also manages wholesale unit trusts. To invest as a Wholesale Investor, investors must fit the criteria as set out in the Financial Markets Conduct Act 2013. This publication is provided in good faith for general information purposes only. Information has been prepared from sources believed to be reliable and accurate at the time of publication, but this is not guaranteed. Information, analysis or views contained herein reflect a judgement at the date of publication and are subject to change without notice. This is not intended to constitute advice to any person. To the extent that any such information, analysis, opinions or views constitutes advice, it does not consider any person’s particular financial situation or goals and, accordingly, does not constitute personalised advice under the Financial Advisers Act 2008. This does not constitute advice of a legal, accounting, tax or other nature to any persons. You should consult your tax adviser in order to understand the impact of investment decisions on your tax position. The price, value and income derived from investments may fluctuate and investors may get back less than originally invested. Where an investment is denominated in a foreign currency, changes in rates of exchange may have an adverse effect on the value, price or income of the investment. Actual performance will be affected by fund charges as well as the timing of an investor’s cash flows into or out of the Fund. Past performance is not indicative of future results, and no representation or warranty, express or implied, is made regarding future performance. Neither Harbour Asset Management Limited nor any other person guarantees repayment of any capital or any returns on capital invested in the investments. To the maximum extent permitted by law, no liability or responsibility is accepted for any loss or damage, direct or consequential, arising from or in connection with this or its contents.